Aroa Biosurgery has received EC Certification for its Endoform® Dermal Template (“EDT”), which allows the company to market and sell this device in the European markets.
Continue ReadingAroa Biosurgery has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s Endoform® Plastics and Reconstructive Matrix, which allows the company to market and sell this device in the USA.
Continue ReadingAroa Biosurgery has successfully raised additional capital from new and existing investors from the USA, Australia and New Zealand.
Continue Reading